Table 1.
Stage I ovarian cancer tumour biomarker sensitivity in patient serum.
Biomarker(s) | Sensitivity at 95% specificity (%) | Sensitivity at 98% specificity (%) |
---|---|---|
HE4 | 45.9 | 30.8 |
CA125 + HE4 | 39.5 | 38.4 |
CA125 + osteopontin | 15.3 | 15.3 |
CA125 | 15.1 | 7.7 |
Osteopontin | 14.7 | 7.6 |
Adapted from Moore et al43.